10x Genomics Inc.

NASDAQ: TXG · Real-Time Price · USD
13.47
0.11 (0.82%)
At close: Aug 18, 2025, 3:59 PM
13.50
0.19%
After-hours: Aug 18, 2025, 07:50 PM EDT
0.82%
Bid 13
Market Cap 1.68B
Revenue (ttm) 624.66M
Net Income (ttm) -157.04M
EPS (ttm) -0.7
PE Ratio (ttm) -19.25
Forward PE -13.09
Analyst Buy
Ask 13.75
Volume 1,742,920
Avg. Volume (20D) 3,846,077.9
Open 13.37
Previous Close 13.36
Day's Range 13.24 - 13.72
52-Week Range 6.78 - 24.76
Beta 2.03

About TXG

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TXG
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for TXG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

10x Genomics Inc. is scheduled to release its earnings on Oct 28, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-3.98%
TXG stock has given up its prior gain. 10x Genomic... Unlock content with Pro Subscription
1 week ago
-3.98%
10x Genomics shares are trading higher after the company reported better-than-expected Q2 financial results and announced it will acquire Scale Biosciences. Also, Barclays raised its price target on the stock from $13 to $15.